Liso-cel Demonstrates Rapid, Durable Responses in Patients with Relapsed/Refractory CLL/SLL
June 24th 2023The phase 1/2 TRANSCEND CLL 004 trial met its primary end point by demonstrating that lisocabtagene maraleucel elicited responses in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Uncracking the Code on Oncology Nurse Satisfaction During a Magnet® Journey
March 28th 2022Two healthcare professionals with Cancer Treatment Centers of America® (CTCA) Phoenix, a comprehensive care and research center recently recognized with Magnet® distinction, discuss the importance of transparency in nursing satisfaction and engagement.
Pet Therapy Touches Lives Beyond Patients With Cancer, Including Caregivers and Providers
September 7th 2021The impact of animal-assisted therapy is felt by more than just patients with cancer, explained Cynthia Ingram, BS, RN, HN-BC, COHN-S. Service animals like her dog, Tori, can also have a positive impact on the well-being of caregivers and health care providers.